BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22153794)

  • 1. Correlation of low SLC22A18 expression with poor prognosis in patients with glioma.
    Chu SH; Ma YB; Feng DF; Zhang H; Zhu ZA; Li ZQ; Jiang PC
    J Clin Neurosci; 2012 Jan; 19(1):95-8. PubMed ID: 22153794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
    Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
    J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of NDRG2 is related to poor overall survival in patients with glioma.
    Li W; Chu D; Chu X; Meng F; Wei D; Li H; Sun B
    J Clin Neurosci; 2011 Nov; 18(11):1534-7. PubMed ID: 21872476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
    Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
    Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C
    Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of PCDH9 predicts prognosis for patients with glioma.
    Wang C; Yu G; Liu J; Wang J; Zhang Y; Zhang X; Zhou Z; Huang Z
    J Clin Neurosci; 2012 Apr; 19(4):541-5. PubMed ID: 22300792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
    He J; Deng Y; Yang G; Xie W
    J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of the SPOP gene is associated with poor prognosis in glioma.
    Ding D; Song T; Jun W; Tan Z; Fang J
    Int J Oncol; 2015 Jan; 46(1):333-41. PubMed ID: 25351530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stratifin expression is a novel prognostic factor in human gliomas.
    Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
    Pathol Res Pract; 2011 Nov; 207(11):674-9. PubMed ID: 21940111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
    Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
    J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of N-Myc downstream-regulated gene 4 influences patient survival in gliomas.
    Li S; Yang B; Li G; He S; Li Y
    Brain Tumor Pathol; 2013 Jan; 30(1):8-14. PubMed ID: 22399192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of microRNA-205 as a potential prognostic indicator for human glioma.
    Hou SX; Ding BJ; Li HZ; Wang L; Xia F; Du F; Liu LJ; Liu YH; Liu XD; Jia JF; Li L; Wu ZL; Zhao G; Zhang ZG; Deng YC
    J Clin Neurosci; 2013 Jul; 20(7):933-7. PubMed ID: 23683741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patients.
    McDonald KL; O'Sullivan MG; Parkinson JF; Shaw JM; Payne CA; Brewer JM; Young L; Reader DJ; Wheeler HT; Cook RJ; Biggs MT; Little NS; Teo C; Stone G; Robinson BG
    J Neuropathol Exp Neurol; 2007 May; 66(5):405-17. PubMed ID: 17483698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forkhead-box A1 transcription factor is a novel adverse prognosis marker in human glioma.
    Wang L; Qin H; Li L; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
    J Clin Neurosci; 2013 May; 20(5):654-8. PubMed ID: 23510544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of Notch1, MMP-2 and MMP-9 and their significance in glioma patients].
    Sun ZF; Wang L; Gu F; Fu L; Li WL; Ma YJ
    Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):26-30. PubMed ID: 22490851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of Jun activation domain-binding protein 1 and phosphorylated p27 expression in prognosis of glioma.
    He SM; Zhao ZW; Wang Y; Zhao JP; Wang L; Hou F; Gao GD
    Brain Tumor Pathol; 2012 Jan; 29(1):3-9. PubMed ID: 21837501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma.
    Mizumatsu S; Tamiya T; Ono Y; Abe T; Matsumoto K; Furuta T; Ohmoto T
    Clin Cancer Res; 1999 Mar; 5(3):551-7. PubMed ID: 10100706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of neuroepithelial-transforming protein 1 confers poor prognosis of patients with gliomas.
    Tu Y; Lu J; Fu J; Cao Y; Fu G; Kang R; Tian X; Wang B
    Jpn J Clin Oncol; 2010 May; 40(5):388-94. PubMed ID: 20304779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezrin expression in tissue microarray of primary and recurrent gliomas.
    Tynninen O; Carpén O; Jääskeläinen J; Paavonen T; Paetau A
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):472-7. PubMed ID: 15488023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.